![Silverback Therapeutics logo](/static/img/stocks/sbtx.png)
Silverback Therapeutics SBTX
$ 6.1
4.99%
Country |
![]() |
IPO year |
2020 |
Industry |
- |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
- |
Employees in the company |
- |
Shares |
95.2 M |
Market Cap[1] |
$ 220 M |
EBITDA (LTM) |
$ -55.8 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.